<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="9094">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02988544</url>
  </required_header>
  <id_info>
    <org_study_id>UF 9751</org_study_id>
    <nct_id>NCT02988544</nct_id>
  </id_info>
  <brief_title>Artificial Shrinkage of Fresh Blastocysts</brief_title>
  <acronym>BlastoCollapse</acronym>
  <official_title>Artificial Shrinkage of Fresh Blastocyst: Impact on Success Rates in Assisted Reproductive Technology</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to determine if collapsing an embryo (or making it fold compactly by
      taking away its fluid) before the transfer in the uterine cavity improves pregnancy rates in
      assisted reproductive technology (ART).

      Women coming to our ART center will be randomized in two groups : the collapsing group and a
      control group.

      Pregnancy rates will be compared in the two groups. A biomarker (cell free DNA) will also be
      determined in each group and correlated to pregnancy occurrence.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective randomized study designed to determine if artificial shrinkage (AS)
      before transfer of embryos impact clinical pregnancy rate in single blastocyst embryo
      transfer (SBET) cycle. Women elected for SBET will be randomized on transfer day in two
      arms:the AS group where blastocoelic cavity is artificially reduced by a laser pulse prior
      to transfer and a control group.

      Clinical pregnancy rates will be compared. Secondarily, rate of monozygotic twin pregnancy
      and cell free DNA concentration in culture medium will be evaluated in the two groups.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>February 2017</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical pregnancy rate embryo transfer</measure>
    <time_frame>4 weeks after embryo transfer</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Infertility Assisted Reproductive Technology</condition>
  <arm_group>
    <arm_group_label>Artificial shrinkage (AS) group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The Artificial shrinkage group where blastocoelic cavity is artificially reduced by a laser pulse prior to transfer</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No intervention on blastocoelic</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Artificial shrinkage</intervention_name>
    <arm_group_label>Artificial shrinkage (AS) group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  eligible patient for transfert of only embryo at the blastocyte step

          -  available patient for a follow up of 12 months

        Exclusion Criteria:

          -  Attempt with frozen embryo or frozen oocyte

          -  Patient has not signed informed consent
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>36 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>ANNA AG GALA, PH</last_name>
    <phone>+33(0)467336404</phone>
    <email>a-gala@chu-montpellier.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>ELODIE ES SCALICI, PH</last_name>
    <phone>+33(0)467336404</phone>
    <email>e-scalici@chu-montpellier.fr</email>
  </overall_contact_backup>
  <verification_date>December 2016</verification_date>
  <lastchanged_date>December 6, 2016</lastchanged_date>
  <firstreceived_date>December 2, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
